The STOP AF Clinical Trial

If you suffer from atrial fibrillation (AF), a common and disabling heart condition that affects up to 3 million Americans, you may be eligible to join a research study underway at Cedars-Sinai Medical Center.

Persons with AF have an irregular heartbeat caused by abnormal electrical signals in the heart. This abnormal heart rhythm can be very uncomfortable and increases the risk for a stroke.

The purpose of the study is to determine whether persons with AF will experience improved outcomes with a new procedure, called cryoablation, compared to currently available medical treatments. The new procedure uses a balloon-tipped catheter to apply freezing energy to the inside of the heart in order to eliminate abnormal electrical pathways.

To find out more about this study, please contact Dr Walter Kerwin at Cedars-Sinai at 310.289.0141. When you call, please make reference to the STOP AF study.